IL149139A0 - Pharmaceutical compositions containing metformin and glyburide - Google Patents

Pharmaceutical compositions containing metformin and glyburide

Info

Publication number: IL149139A0
Authority: IL; Israel
Prior art keywords: glyburide; pharmaceutical compositions; compositions containing; containing metformin; metformin
Prior art date: 1999-11-03

Application number

IL14913900A

Other languages

English (en)

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-03

Filing date

2000-10-13

Publication date

2002-11-10

1999-11-03 Priority claimed from US09/432,465 external-priority patent/US6586438B2/en

2000-10-13 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

2002-11-10 Publication of IL149139A0 publication Critical patent/IL149139A0/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Oncology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Communicable Diseases (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

IL14913900A 1999-11-03 2000-10-13 Pharmaceutical compositions containing metformin and glyburide IL149139A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US09/432,465 US6586438B2 (en)	1999-11-03	1999-11-03	Antidiabetic formulation and method
US09/460,920 US7598262B2 (en)	1999-11-03	1999-12-14	Method for treating diabetes
PCT/US2000/028311 WO2001032157A2 (en)	1999-11-03	2000-10-13	Pharmaceutical composition comprising a combination of metformin and glibenclamide

Publications (1)

Publication Number	Publication Date
IL149139A0 true IL149139A0 (en)	2002-11-10

Family

ID=27029501

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14913900A IL149139A0 (en)	1999-11-03	2000-10-13	Pharmaceutical compositions containing metformin and glyburide

Country Status (23)

Country	Link
EP (1)	EP1229918B1 (zh)
JP (1)	JP5183844B2 (zh)
KR (1)	KR20070089259A (zh)
CN (1)	CN1450902A (zh)
AR (1)	AR026356A1 (zh)
AT (1)	ATE390140T1 (zh)
AU (1)	AU780106B2 (zh)
BR (1)	BR0015294A (zh)
CA (1)	CA2389928C (zh)
EE (1)	EE05260B1 (zh)
HU (1)	HU229352B1 (zh)
IL (1)	IL149139A0 (zh)
LT (1)	LT5058B (zh)
LV (1)	LV12910B (zh)
MX (1)	MXPA02004282A (zh)
NO (1)	NO330026B1 (zh)
NZ (1)	NZ518278A (zh)
PL (1)	PL199278B1 (zh)
RU (1)	RU2275915C2 (zh)
SK (1)	SK287810B6 (zh)
TW (1)	TWI280125B (zh)
UY (1)	UY26424A1 (zh)
WO (1)	WO2001032157A2 (zh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2816840B1 (fr)	2000-11-17	2004-04-09	Flamel Tech Sa	Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation
FR2825023B1 (fr) *	2001-05-23	2005-04-15	Flamel Tech Sa	Forme pharmaceutique orale antidiabetique "une prise par jour"comprenant une biguanide et au moins un autre principe actif
WO2003011273A1 (en) *	2001-07-31	2003-02-13	The Governement Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services	Metformin in the treatment of hyperglycemic conditions
EP1492511B3 (fr)	2002-04-09	2012-05-02	Flamel Technologies	Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
EP1515701B1 (en)	2002-06-17	2014-09-17	Inventia Healthcare Private Limited	Process for the manufacture of multilayer tablet compositions comprising thiazolidinedione and biguanide
WO2005046687A1 (en) *	2003-10-30	2005-05-26	Tioga Pharmaceuticals, Inc.	Use of selective opiate receptor modulators in the treatment of neuropathy
TWI350751B (en) *	2003-12-19	2011-10-21	Omega Bio Pharma Ip3 Ltd	Pharmaceutical compositions for treating diabetes
RU2387445C2 (ru) *	2004-05-03	2010-04-27	ОМЕГА БИО-ФАРМА (Ай.Пи. 3) ЛИМИТЕД	Материалы и способы модуляции метаболизма
MY159203A (en)	2007-07-19	2016-12-30	Takeda Pharmaceuticals Co	Solid preparation comprising alogliptin and metformin hydrochloride
KR101552187B1 (ko)	2007-09-10	2015-09-10	얀센 파마슈티카 엔.브이.	Ｓｇｌｔ 억제제로서 유용한 화합물의 제조 방법
CA2740685C (en)	2008-10-17	2018-09-11	Sanofi-Aventis Deutschland Gmbh	Combination of an insulin and a glp-1 agonist
US9056850B2 (en)	2008-10-17	2015-06-16	Janssen Pharmaceutica N.V.	Process for the preparation of compounds useful as inhibitors of SGLT
US20110009347A1 (en)	2009-07-08	2011-01-13	Yin Liang	Combination therapy for the treatment of diabetes
AU2010317995B2 (en)	2009-11-13	2014-04-17	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine
JP5973918B2 (ja)	2009-11-13	2016-08-23	サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	Ｇｌｐ−１アゴニスト及びメチオニンを含む薬学的組成物
JP6227406B2 (ja)	2010-05-11	2017-11-08	ヤンセンファーマシューティカエヌ．ベー．	ＳＧＬＴの阻害剤としての１−（β−Ｄ−グルコピラノシル）−２−チエニル−メチルベンゼン誘導体を含有する医薬製剤
JP6199186B2 (ja)	2010-08-30	2017-09-20	サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	２型糖尿病の治療用の医薬の製造のためのａｖｅ００１０の使用
BR112013019744A2 (pt) *	2011-02-02	2016-11-22	Sanofi Aventis Deutschland	prevenção de hipoglicemia em pacientes com diabetes mellitus tipo 2
US20120277147A1 (en) *	2011-03-29	2012-11-01	Sanofi-Aventis Deutschland Gmbh	Prevention of hypoglycaemia in diabetes mellitus type 2 patients
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
TWI559929B (en)	2011-09-01	2016-12-01	Sanofi Aventis Deutschland	Pharmaceutical composition for use in the treatment of a neurodegenerative disease
HRP20230470T1 (hr)	2014-12-12	2023-07-21	Sanofi-Aventis Deutschland Gmbh	Formulacija fiksnog omjera inzulin glargin/liksisenatid
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療
US20170071970A1 (en)	2015-09-15	2017-03-16	Janssen Pharmaceutica Nv	Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
CN110804017A (zh) *	2019-10-31	2020-02-18	天津大学	磺酰脲化合物与二甲双胍成盐、制备方法和应用
CN113143940A (zh) *	2020-12-30	2021-07-23	成都恒瑞制药有限公司	一种抗糖尿病药物组合物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3174901A (en)	1963-01-31	1965-03-23	Jan Marcel Didier Aron Samuel	Process for the oral treatment of diabetes
DE3833439A1 (de) *	1988-10-01	1991-09-12	Hoechst Ag	Verfahren zur mikronisierung von glibenclamid
DK36392D0 (da)	1992-03-19	1992-03-19	Novo Nordisk As	Anvendelse af kemisk forbindelse
TWI238064B (en)	1995-06-20	2005-08-21	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes
IT1276130B1 (it) *	1995-11-14	1997-10-27	Gentili Ist Spa	Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
CZ298469B6 (cs)	1997-06-18	2007-10-10	Smithkline Beecham Plc	Farmaceutický prostredek obsahující 5-[4-/2-(N-methyl-N-(2-pyridyl)amino)ethoxy/benzyl]thiazolidin-2,4-dion a metformin, a lécivo pro lécení diabetesmellitus
CA2312990C (en) *	1997-12-08	2008-04-29	Bristol-Myers Squibb Company	Novel salts of metformin and method
ATE250418T1 (de) *	1998-07-15	2003-10-15	Merck Sante Sas	Tabletten enthaltend eine kombination von glibenclamid und metformin
EP2620443A1 (en)	2012-01-25	2013-07-31	Galecto Biotech AB	Novel galactoside inhibitors of galectins

2000
- 2000-10-13 HU HU0300218A patent/HU229352B1/hu unknown
- 2000-10-13 AT AT00972122T patent/ATE390140T1/de not_active IP Right Cessation
- 2000-10-13 WO PCT/US2000/028311 patent/WO2001032157A2/en active IP Right Grant
- 2000-10-13 MX MXPA02004282A patent/MXPA02004282A/es active IP Right Grant
- 2000-10-13 EP EP00972122A patent/EP1229918B1/en not_active Expired - Lifetime
- 2000-10-13 NZ NZ518278A patent/NZ518278A/en not_active IP Right Cessation
- 2000-10-13 AU AU10826/01A patent/AU780106B2/en not_active Expired
- 2000-10-13 CN CN00818032A patent/CN1450902A/zh active Pending
- 2000-10-13 IL IL14913900A patent/IL149139A0/xx unknown
- 2000-10-13 EE EEP200200242A patent/EE05260B1/xx unknown
- 2000-10-13 BR BR0015294-3A patent/BR0015294A/pt not_active Application Discontinuation
- 2000-10-13 KR KR1020077018914A patent/KR20070089259A/ko not_active Application Discontinuation
- 2000-10-13 SK SK500-2002A patent/SK287810B6/sk not_active IP Right Cessation
- 2000-10-13 RU RU2002114820/14A patent/RU2275915C2/ru active
- 2000-10-13 PL PL364885A patent/PL199278B1/pl unknown
- 2000-10-13 CA CA2389928A patent/CA2389928C/en not_active Expired - Lifetime
- 2000-10-13 JP JP2001534362A patent/JP5183844B2/ja not_active Expired - Fee Related
- 2000-10-27 TW TW089122713A patent/TWI280125B/zh not_active IP Right Cessation
- 2000-11-02 UY UY26424A patent/UY26424A1/es not_active Application Discontinuation
- 2000-11-03 AR ARP000105805A patent/AR026356A1/es unknown
2002
- 2002-05-02 NO NO20022087A patent/NO330026B1/no not_active IP Right Cessation
- 2002-05-24 LT LT2002063A patent/LT5058B/lt not_active IP Right Cessation
- 2002-06-03 LV LVP-02-94A patent/LV12910B/lv unknown

Also Published As

Publication number	Publication date
BR0015294A (pt)	2003-07-15
PL199278B1 (pl)	2008-09-30
JP5183844B2 (ja)	2013-04-17
SK287810B6 (sk)	2011-10-04
LT5058B (lt)	2003-09-25
LT2002063A (en)	2003-06-25
ATE390140T1 (de)	2008-04-15
NZ518278A (en)	2004-10-29
TWI280125B (en)	2007-05-01
AU780106B2 (en)	2005-03-03
NO330026B1 (no)	2011-02-07
HUP0300218A2 (hu)	2003-06-28
CA2389928A1 (en)	2001-05-10
RU2275915C2 (ru)	2006-05-10
EE200200242A (et)	2003-12-15
NO20022087D0 (no)	2002-05-02
WO2001032157A3 (en)	2002-01-24
PL364885A1 (en)	2004-12-27
HUP0300218A3 (en)	2006-02-28
HU229352B1 (en)	2013-11-28
RU2002114820A (ru)	2004-03-10
LV12910B (en)	2003-05-20
NO20022087L (no)	2002-06-24
CN1450902A (zh)	2003-10-22
KR20070089259A (ko)	2007-08-30
SK5002002A3 (en)	2004-05-04
MXPA02004282A (es)	2003-02-17
EP1229918A2 (en)	2002-08-14
AR026356A1 (es)	2003-02-05
WO2001032157A2 (en)	2001-05-10
EE05260B1 (et)	2010-02-15
AU1082601A (en)	2001-05-14
EP1229918B1 (en)	2008-03-26
UY26424A1 (es)	2001-05-31
JP2003519621A (ja)	2003-06-24
CA2389928C (en)	2010-03-23

Publication	Publication Date	Title
IL149139A0 (en)	2002-11-10	Pharmaceutical compositions containing metformin and glyburide
IL149138A0 (en)	2002-11-10	Pharmaceutical compositions containing metformin
HUP0203939A3 (en)	2004-12-28	Pharmaceutical compounds and compositions containing them and their use
HUP0203378A3 (en)	2004-07-28	Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0200714A3 (en)	2003-01-28	Pharmaceutical compounds, pharmaceutical compositions containing them and their use
PT1213020E (pt)	2009-04-24	Compostos e composições farmacêuticas com actividade supressora do apetite
IL150383A0 (en)	2002-12-01	Glyburide and pharmaceutical compositions containing the same
HUP0203700A3 (en)	2004-01-28	N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents and pharmaceutical compositions containing them
IL155196A0 (en)	2003-11-23	Benzamide derivatives and pharmaceutical compositions containing the same
HUP0001309A3 (en)	2000-12-28	1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
HUP0200588A2 (hu)	2002-07-29	Diarilszármazékok és azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0105204A3 (en)	2002-05-28	Substituted phenethylamine derivatives and pharmaceutical compositions containing them
HUP0000137A3 (en)	2001-03-28	Controller-release pharmaceutical composition containing anangetics
HUP0200747A3 (en)	2003-02-28	Pharmaceutical compounds and pharmaceutical compositions containing them
IL137505A (en)	2005-07-25	Pharmaceutical compositions containing tramadol
HUP9802132A3 (en)	2000-04-28	Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them
HUP0201910A3 (en)	2006-03-28	Novel aminobenzophenones, pharmaceutical compositions containing them and their use
HUP0001940A3 (en)	2002-09-30	Benzisothiazole derivatives, their use and pharmaceutical compositions containing them
IL133928A0 (en)	2001-04-30	Pharmaceutical composition containing peptichemio
HUP0200121A3 (en)	2002-11-28	Calcilytic compounds, pharmaceutical compositions containing them and their use
HUP0200055A3 (en)	2002-10-28	16-hydroxyestrienes and pharmaceutical compositions containing the same
HUP0003189A3 (en)	2001-04-28	Pharmaceutical composition comprising fexofenadine and its derivatives
HUP0101733A3 (en)	2001-12-28	Pharmaceutical compositions containing sulfonyl-dipeptides and their use
HUP0202732A3 (en)	2003-12-29	Amide compounds and pharmaceutical compositions containing them
HUP0201443A2 (en)	2002-08-28	1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them